Unfractionated heparin (UFH) requires frequent monitoring due to variability in patient response; used more in situations requiring rapid anticoagulation adjustment, such as in acute settings. Low-molecular-weight heparin (LMWH) has more predictable pharmacokinetics, allowing for fixed dosing and less monitoring; often used in prevention and treatment of thromboembolism in outpatient settings.